Insulinotropic Potential of <i>Moxifloxacin</i> and <i>Gemifloxacin:</i> An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial
Fluoroquinolones (FQs) have been reported to cause dysglycemia in both diabetic and non-diabetic patients. However, diabetic patients are usually on polypharmacy, so we cannot attribute the dysglycemia specifically to FQs. To answer the question as to whether <i>Moxifloxacin</i> and <...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-01-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/11/2/148 |